Benefit-cost aspects of rubella immunization.
There are substantial net economic benefits from rubella immunization. This is true for immunization of infants of both sexes and of teenage girls. The ability to use combined measles-rubella vaccine and the occurrence of herd immunity favors vaccination of infants. However, even more important than the choice of strategy of immunization is the development of programs for full implementation of the chosen strategy.
D000293:Adolescent; D000328:Adult; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000191:economics / Q000517:prevention & control; D012409:Rubella / Q000151:congenital / Q000191:economics / Q000517:prevention & control*; D012411:Rubella Vaccine; D014611:Vaccination / Q000191:economics*
D012411:Rubella Vaccine